ADDISON, Texas – 7 July, 2021 –
For the seventh year in a row, the Journal of Heart and Lung Transplantation’s
Impact Factor earned the publication the number one ranking in the transplantation category. The Journal
has also ranked number three in Surgery (from four in 2020), number five in Respiratory (from seven in 2020), and maintained its rank of number 13 in the highly competitive Cardiovascular category.
overall impact factor was 10.247 and the Immediacy index, a measure of how much attention papers get shortly after publication and citation, has more than tripled to reach 7.095 (up from 2.3). The Impact Factor is published in the annual Journal Citation Reports (JCR), and is determined by the number of 2020 citations accumulated for JHLT
manuscripts published in the previous two years.
“I am thrilled that the JHLT
has received its highest impact factor score ever of 10.247 for the 2020 annual cycle and continues to rank 1st among many equals in the Transplantation category,” said Mandeep R. Mehra, MD
, former Editor in Chief of JHLT
and the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital and Harvard Medical School in Boston, MA USA. “I am equally delighted that the Journal
is now in the secure and steady hands of the new editorial team led by Daniel R. Goldstein, and will watch with pride as the JHLT
continues its ascent as the premier scientific voice of our collective field of advanced heart and lung disease.”
In addition to its rising Impact Factor and Immediacy Index, in 2020 the JHLT
had 15,107 citations, a 21 percent increase from 2019’s citation total of 12,465. The article Influence Score, a measure of how much attention a JHLT
paper would acquire when normalized for various categories, has maintained at 2.858. Any score over 1.00 indicates each article has above-average influence.
“I’m truly honored to take over JHLT
from Dr. Mehra, who guided the Journal
to new heights including achieving its highest impact factor of 10.247,” said Daniel R. Goldstein, MD
, Editor in Chief and Eliza Maria Mosher Collegiate Professor in Internal Medicine at the University of Michigan in Ann Arbor, MI USA. “With our new editorial team and structure, our goal is to continue JHLT’s
ascendency and be the leading journal in the fields of organ transplantation, advanced heart and lung disease, and pulmonary hypertension. JHLT
is a centerpiece of ISHLT and we are fortunate to enjoy the full support of the Society.”
is the official publication of the International Society for Heart and Lung Transplantation (ISHLT). ISHLT is the only international interdisciplinary organization focused on interventions for advanced heart and lung disease, including transplantation.
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With more than 3,800 members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.
The official publication of the International Society for Heart and Lung Transplantation, the Journal of Heart and Lung Transplantation brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the Journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas. For more information, visit www.jhltonline.org.